Sign in
4

Changes in Ownership

Gossamer Bio, Inc. Filed Acc 0001728117-22-000104

Options or other derivatives

  • President & CEO acquired 544,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hasnain Faheem President & CEO 2022-12-07 Grant or award · Stock Option (Right to Buy) +544,500 544,500 D
Loading xslF345X03/wf-form4_167062400607119.xml…